849426-73-9

Basic information

• Product Name: N-{3-amino-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-N-methylacetamide hydrochloric acid salt
• Synonyms: N-{3-amino-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-N-methylacetamide hydrochloric acid salt
• CAS NO: 849426-73-9
• Molecular Weight: 313.827
• Mol File: 849426-73-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: N-{3-amino-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-N-methylacetamide hydrochloric acid salt(CAS DataBase Reference)
• NIST Chemistry Reference: N-{3-amino-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-N-methylacetamide hydrochloric acid salt(849426-73-9)
• EPA Substance Registry System: N-{3-amino-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-N-methylacetamide hydrochloric acid salt(849426-73-9)

Safety Data

• Hazardous Substances Data: 849426-73-9(Hazardous Substances Data)

Upstream product

• 849351-11-7 N-{3-amino-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-N-methylacetamide 
• 7647-01-0 hydrogenchloride 
• 849351-10-6 N-methyl-N-{3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}acetamide 

Relevant articles and documents

Benzimidazole derivatives and their use as cannabinoid receptor ligands I

Compounds of Formula I, or pharmaceutically acceptable salts thereof: (I) wherein R1, R2, R3, R4, and R5 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF IIII

Compounds of Formula I, or pharmaceutically acceptable salts thereof (I) wherein G, R1, R2, R3, R4, and R5 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF

Compounds of Formula (I) or pharmaceutically acceptable salts thereof; wherein R1, R2, R3, R4, n and Ar are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.